Mobile

A study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ investigational vaccine GSK2838504A when administered to chronic obstructive pulmonary disease (COPD) ...

Update Il y a 5 ans
Reference: EUCTR2013-003062-13

A study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ investigational vaccine GSK2838504A when administered to chronic obstructive pulmonary disease (COPD) patients with persistent airflow obstruction

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To describe the safety and reactogenicity of the investigational vaccine

Inclusion criteria

  • COPD

Links